Sparsentan

Overview

Sparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with K i s of 0.8 and 9.3 nM, respectively.

Application

Products | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Hypertension | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Endocrinology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Angiotensin Receptor | Products > Signaling Pathways > Endothelin Receptor

Product Information

• Catalog No.: HY-17621
• CAS No.: 254740-64-2
• Molecular Formula: C32H40N4O5S
• Molecular Weight: 592.75
• Purity: 99.87%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (3.51 mM); Clear solution
• Availability: In-stock

Source

Original product source